spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

SAPHEX 2018

SAPHEX 2018

1-2 November 2018
Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry.

The exhibition brings together all the key suppliers to the region’s pharmaceutical manufacturing base, exhibitors presenting a full range of APIs, excipients, and drug formulations; pharmaceutical packaging solutions; processing machinery and equipment; laboratory equipment; clean room technology; and much, much more!

The exhibition attracts decision makers from all the leading pharmaceutical manufacturers in the region and from across Africa, and provides a forum for manufacturers and their suppliers to forge long-standing, mutually beneficial partnerships to ensure future commercial success.
phone 0044 (0) 203 198 9621
email jessica@saphex.co.za
web www.saphex.co.za
email Gallagher Convention Centre, Midrand, South Africa
 
Print this page
Send to a friend
   
spacer
Industry Events

On Helix 2018

10-11 July 2018, The Cambridge Building, Babraham Research Campus

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).
More info >>

Banner of T3_events_97 on Samedan

White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>


News and Press Releases

Charles River Laboratories Expands Services for Early Discovery Screening

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its service capabilities in early discovery screening. Charles River is the first contract research organization to offer clients access to Apricot Designs' Dual Arm (ADDA) system for high-throughput absorption, distribution, metabolism, and excretion (HT-ADME) to identify potential lead compounds in North America and Europe. Additionally, the Company has geographically expanded its pharmacokinetic (PK) capabilities at sites central to major pharmaceutical and biotechnology hubs.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement